Clinical study of Shenshi Qianghuo Dihuang Decoction in the treatment of Rheumatoid arthritis from the perspective of ''7+1''
Phase 1
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- ITMCTR2000003850
- Lead Sponsor
- Shanghai Traditional Chinese Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Meet the diagnostic criteria of rheumatoid arthritis, age 18-75 years old, male and female can be; The informed consent has been signed.
Exclusion Criteria
Having other diseases or drug contraindications; Pregnant and lactating women.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Shenshi Qianghuo Dihuang Decoction's efficacy in rheumatoid arthritis?
How does Shenshi Qianghuo Dihuang Decoction compare to standard-of-care therapies for rheumatoid arthritis in phase I trials?
Are there specific biomarkers associated with response to Shenshi Qianghuo Dihuang Decoction in rheumatoid arthritis patients?
What are the potential adverse events and management strategies for Shenshi Qianghuo Dihuang Decoction in phase I rheumatoid arthritis trials?
What are the key drug targets and pathways in traditional Chinese medicine formulations like Shenshi Qianghuo Dihuang Decoction for rheumatoid arthritis?